2BB score and signals
Bicycle Therapeutics’s current 2BB score is 39 out of 100, built from the signal categories below.
| Signal | Score | Reading |
|---|---|---|
| Activity | 33 | Low |
| Momentum | 32 | Weakening |
| Financial strength | 24 | Weak |
| Quality | 96 | Very Strong |
| Risk | 45 | Moderate |
Bicycle Therapeutics (BCYC) Stock Score & Signals
Bicycle Therapeutics (BCYC) trades on NASDAQ. It operates in the Health Care sector, Biotechnology: Pharmaceutical Preparations industry. Its current 2BB score is 39 out of 100.
Company facts
| CEO | Kevin Lee |
| Founded | 2009 |
| Employees | 288 |
| 52-week range | $3.33 – $9.08 |
Recent earnings
| Report date | EPS actual | EPS estimate | Revenue actual | Revenue estimate |
|---|---|---|---|---|
| 2027-03-15 | — | -0.4468 | — | $1.86M |
| 2026-10-28 | — | -0.4417 | — | $6.19M |
| 2026-08-06 | — | -0.5753 | — | $4.87M |